GlassScriptPhysician profile
Carlos E Wiegering
NPI 1265591580
$5,716.21
in general payments reported to CMS, 2019-2025
11 companies · $1,957 in 2025
The $1,957 reported for 2025 was more than what 83% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $154 · 2021: $259 · 2022: $663 · 2023: $2,464 · 2024: $89.83 · 2025: $1,957.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $2,060 · Food and Beverage: $1,347 · Travel and Lodging: $1,104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $2,060.47 |
| Food and Beverage | $1,346.75 |
| Travel and Lodging | $1,103.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Health Care Systems INC. | $2,060.47 | 2023 | |
| Smith+Nephew, INC. | $1,924.56 | 2019-2025 | Pico, Collagenase Santyl, Versajet |
| Tela Bio, INC. | $476.87 | 2020-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Musculoskeletal Transplant Foundation INC. | $456.20 | 2022 | |
| Biotissue Holdings INC. | $455.52 | 2021-2025 | |
| Allergan, INC. | $180.94 | 2019-2020 | |
| Convatec INC. | $62.82 | 2024-2025 | |
| Kerecis Limited | $36.22 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Integra Lifesciences Corporation | $31.49 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Organogenesis INC. | $24.25 | 2023 | Puraply |
| Amniox Medical, INC. | $6.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Wiegering listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.